Biostar Microtech International Corp (2399) - Net Assets

Latest as of March 2026: NT$2.46 Billion TWD ≈ $77.59 Million USD

Based on the latest financial reports, Biostar Microtech International Corp (2399) has net assets worth NT$2.46 Billion TWD (≈ $77.59 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$3.10 Billion ≈ $97.63 Million USD) and total liabilities (NT$636.03 Million ≈ $20.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Biostar Microtech International Corp's equity to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$2.46 Billion
% of Total Assets 79.48%
Annual Growth Rate 2.83%
5-Year Change -9.48%
10-Year Change -3.91%
Growth Volatility 13.87

Biostar Microtech International Corp - Net Assets Trend (2002–2025)

This chart illustrates how Biostar Microtech International Corp's net assets have evolved over time, based on quarterly financial data. See 2399 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Biostar Microtech International Corp (2002–2025)

The table below shows the annual net assets of Biostar Microtech International Corp from 2002 to 2025. For live valuation and market cap data, see market value of Biostar Microtech International Corp.

Year Net Assets Change
2025-12-31 NT$2.20 Billion
≈ $69.34 Million
+1.42%
2024-12-31 NT$2.17 Billion
≈ $68.36 Million
+1.14%
2023-12-31 NT$2.15 Billion
≈ $67.60 Million
-4.53%
2022-12-31 NT$2.25 Billion
≈ $70.81 Million
-7.57%
2021-12-31 NT$2.43 Billion
≈ $76.60 Million
+13.12%
2020-12-31 NT$2.15 Billion
≈ $67.72 Million
-6.63%
2019-12-31 NT$2.30 Billion
≈ $72.53 Million
+0.79%
2018-12-31 NT$2.28 Billion
≈ $71.96 Million
-13.20%
2017-12-31 NT$2.63 Billion
≈ $82.90 Million
+14.89%
2016-12-31 NT$2.29 Billion
≈ $72.16 Million
-1.86%
2015-12-31 NT$2.33 Billion
≈ $73.53 Million
-4.05%
2014-12-31 NT$2.43 Billion
≈ $76.63 Million
-6.12%
2013-12-31 NT$2.59 Billion
≈ $81.62 Million
+1.44%
2012-12-31 NT$2.55 Billion
≈ $80.46 Million
-6.65%
2011-12-31 NT$2.74 Billion
≈ $86.20 Million
+2.90%
2010-12-31 NT$2.66 Billion
≈ $83.77 Million
-2.06%
2009-12-31 NT$2.71 Billion
≈ $85.54 Million
+17.35%
2008-12-31 NT$2.31 Billion
≈ $72.89 Million
+1.21%
2007-12-31 NT$2.29 Billion
≈ $72.02 Million
+14.48%
2006-12-31 NT$2.00 Billion
≈ $62.91 Million
+48.96%
2005-12-31 NT$1.34 Billion
≈ $42.23 Million
+16.28%
2004-12-31 NT$1.15 Billion
≈ $36.32 Million
-17.66%
2003-12-31 NT$1.40 Billion
≈ $44.11 Million
+20.95%
2002-12-31 NT$1.16 Billion
≈ $36.47 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Biostar Microtech International Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 51.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings NT$66.49 Million 3.02%
Common Stock NT$1.78 Billion 80.93%
Other Comprehensive Income NT$286.52 Million 13.02%
Other Components NT$66.78 Million 3.03%
Total Equity NT$2.20 Billion 100.00%

Biostar Microtech International Corp Competitors by Market Cap

The table below lists competitors of Biostar Microtech International Corp ranked by their market capitalization.

Company Market Cap
SPCG Public Company Limited
BK:SPCG
$291.24 Million
Coltene Holding AG
SW:CLTN
$291.30 Million
Cymechs Inc
KQ:160980
$291.32 Million
Shandong Sinoglory Health
SHG:603182
$291.35 Million
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
$291.11 Million
NOCIL Limited
NSE:NOCIL
$291.03 Million
Camlin Fine Sciences Limited
NSE:CAMLINFINE
$291.02 Million
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671
$291.00 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Biostar Microtech International Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,169,929,000 to 2,200,790,000, a change of 30,861,000 (1.4%).
  • Net income of 26,160,000 contributed positively to equity growth.
  • Other comprehensive income increased equity by 5,443,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$26.16 Million +1.19%
Other Comprehensive Income NT$5.44 Million +0.25%
Other Changes NT$-742.00K -0.03%
Total Change NT$- 1.42%

Book Value vs Market Value Analysis

This analysis compares Biostar Microtech International Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.11x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 8.02x to 4.11x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 NT$6.47 NT$51.90 x
2005-12-31 NT$7.53 NT$51.90 x
2006-12-31 NT$11.21 NT$51.90 x
2007-12-31 NT$12.83 NT$51.90 x
2008-12-31 NT$12.99 NT$51.90 x
2009-12-31 NT$15.05 NT$51.90 x
2010-12-31 NT$14.65 NT$51.90 x
2011-12-31 NT$15.08 NT$51.90 x
2012-12-31 NT$14.21 NT$51.90 x
2013-12-31 NT$14.37 NT$51.90 x
2014-12-31 NT$13.60 NT$51.90 x
2015-12-31 NT$13.10 NT$51.90 x
2016-12-31 NT$12.86 NT$51.90 x
2017-12-31 NT$13.32 NT$51.90 x
2018-12-31 NT$11.17 NT$51.90 x
2019-12-31 NT$11.23 NT$51.90 x
2020-12-31 NT$12.02 NT$51.90 x
2021-12-31 NT$13.48 NT$51.90 x
2022-12-31 NT$12.56 NT$51.90 x
2023-12-31 NT$12.05 NT$51.90 x
2024-12-31 NT$12.17 NT$51.90 x
2025-12-31 NT$12.62 NT$51.90 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Biostar Microtech International Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.19%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.51%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 1.19x
  • Recent ROE (1.19%) is below the historical average (4.88%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 11.73% 2.77% 1.65x 2.56x NT$20.05 Million
2003 17.46% 4.32% 1.91x 2.12x NT$104.43 Million
2004 -12.44% -2.57% 2.08x 2.33x NT$-258.72 Million
2005 13.26% 2.82% 2.08x 2.26x NT$43.66 Million
2006 12.51% 3.24% 2.13x 1.81x NT$50.15 Million
2007 18.70% 4.55% 2.24x 1.83x NT$198.81 Million
2008 8.34% 2.91% 1.95x 1.47x NT$-38.44 Million
2009 14.99% 5.28% 1.69x 1.68x NT$135.58 Million
2010 10.17% 3.91% 1.76x 1.48x NT$4.54 Million
2011 11.17% 4.40% 1.68x 1.51x NT$31.92 Million
2012 4.58% 2.18% 1.42x 1.47x NT$-138.48 Million
2013 4.73% 2.66% 1.20x 1.49x NT$-136.46 Million
2014 -2.72% -1.59% 1.24x 1.38x NT$-309.34 Million
2015 -4.47% -3.69% 0.91x 1.34x NT$-337.71 Million
2016 -1.43% -1.09% 0.94x 1.39x NT$-261.85 Million
2017 4.21% 2.92% 0.93x 1.55x NT$-138.23 Million
2018 -12.22% -8.00% 1.00x 1.52x NT$-442.28 Million
2019 0.37% 0.44% 0.54x 1.56x NT$-192.59 Million
2020 6.64% 6.78% 0.75x 1.31x NT$-72.25 Million
2021 14.88% 13.03% 0.84x 1.36x NT$118.53 Million
2022 0.57% 0.57% 0.80x 1.25x NT$-211.89 Million
2023 -5.28% -4.84% 0.84x 1.30x NT$-327.91 Million
2024 0.31% 0.33% 0.77x 1.21x NT$-210.37 Million
2025 1.19% 1.51% 0.66x 1.19x NT$-193.92 Million

Industry Comparison

This section compares Biostar Microtech International Corp's net assets metrics with peer companies in the Computer Hardware industry.

Industry Context

  • Industry: Computer Hardware
  • Average net assets among peers: $32,602,043,000
  • Average return on equity (ROE) among peers: 4.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Biostar Microtech International Corp (2399) NT$2.46 Billion 11.73% 0.26x $291.22 Million
Solytech Enterprise Corp (1471) $2.65 Billion 1.18% 0.39x $54.97 Million
Lite-On Technology Corp (2301) $74.14 Billion 13.51% 1.37x $15.02 Billion
Microtek International Inc (2305) $2.23 Billion 0.30% 0.28x $195.44 Million
Kinpo Electronics Inc (2312) $17.40 Billion 0.68% 1.29x $1.65 Billion
CMC Magnetics Corp (2323) $16.86 Billion -6.42% 0.39x $386.11 Million
Compal Electronics Inc (2324) $31.11 Billion 0.00% 0.62x $5.12 Billion
Elitegroup Computer Systems Co Ltd (2331) $9.21 Billion 26.14% 1.49x $390.74 Million
Ritek Corp (2349) $33.11 Billion -3.94% 0.65x $298.32 Million
Qisda Corp (2352) $58.96 Billion 8.46% 1.90x $1.53 Billion
Acer Inc (2353) $80.34 Billion 6.14% 1.60x $3.31 Billion

About Biostar Microtech International Corp

TW:2399 Taiwan Computer Hardware
Market Cap
$291.22 Million
NT$9.24 Billion TWD
Market Cap Rank
#15075 Global
#674 in Taiwan
Share Price
NT$51.90
Change (1 day)
-1.70%
52-Week Range
NT$17.25 - NT$52.80
All Time High
NT$52.80
About

Biostar Microtech International Corp. engages in the design, development, manufacture, and marketing of various networking solutions in Taiwan and internationally. The company provides edge computing, industrial automation, EV chargers, digital signage, POS and KIOSK systems, PC (MB/VGA), AI workstations, and human-machine interface solutions. It also offers industrial PCs, motherboards, graphics… Read more